U.S. commits $2B to quantum foundries, betting supply chain controls the race

On May 21, the Department of Commerce quietly reshaped the global quantum chip supply chain by signing nine letters of intent worth $2.013 billion in CHIPS and Science Act incentives, the single largest federal bet on quantum manufacturing in U.S. history. The centerpiece is not a well-known quantum startup but a new IBM spin-out called Anderon, described as America's first pure-play quantum chip foundry. IBM is backing Anderon with $1 billion of its own capital, matched by a $1 billion CHIPS award, plus significant IP and workforce. The company will operate a 300-millimeter wafer fabrication facility in Albany, New York. That last detail matters more than the headline figure. A 300mm fab is not a modest upgrade; it is the manufacturing node that silicon reached in the early 2000s. For quantum, it represents a jump from custom boutique production to something resembling industrial scale.

The shift to 300mm does two things at once. According to IBM research director Jay Gambetta, speaking at IBM Think 2026, the larger wafer increases device output 30 times over while reducing per-unit complexity cost. Put another way: Anderon's fab produces quantum chips at volumes and margins that make certain quantum architectures, particularly superconducting qubits and eventually other modalities, economically viable for the first time at scale. GlobalFoundries will operate a second domestic quantum foundry with $375 million in proposed CHIPS funding, also supporting multiple modalities including trapped-ion, photonic, and silicon-spin approaches. Neither Anderon nor GlobalFoundries exists yet as operating facilities; both are LOIs pending formal award. But the federal government is now taking minority, non-controlling equity stakes in each recipient company, a structural innovation that ties public infrastructure investment directly to commercial success and creates alignment between federal supply-chain objectives and company execution incentives.

The nine awardees are not a random slice of the quantum industry. Quantinuum, Rigetti, Atom Computing, D-Wave, Infleqtion, and PsiQuantum each receive $100 million in proposed CHIPS funding; Diraq receives up to $38 million. The portfolio spans every major hardware modality, superconducting, trapped-ion, photonic, neutral-atom, and silicon-spin, ensuring that the U.S. does not bet the entire supply chain on a single architecture that might fail to scale. Quantinuum's trapped-ion systems will benefit from the CHIPS award to address manufacturing bottlenecks in integrated photonics and optical components. PsiQuantum's photonic approach gets $100 million to develop high-temperature single-photon detectors and ultra-low-loss photonic packaging. The specificity matters: these are not generic R&D grants but targeted capital deployed against concrete technical hurdles that have constrained each modality's path to fault tolerance. This is applied industrial policy, not basic science funding.

But the award also reveals who is and is not in the federal tent. Notable quantum companies, IonQ, Rigetti's earlier backers, private trapped-ion startups outside the Quantinuum orbit, and newer photonic players not aligned with PsiQuantum or Anderon's roadmap, are not listed. For IonQ specifically, the exclusion is striking given its market cap and venture backing; the company may have declined to participate or faced unseen evaluation criteria. For smaller startups with proprietary quantum architectures, the LOI portfolio effectively creates a domestic supply-chain moat. If Anderon and GlobalFoundries become the only accessible U.S. quantum foundries, any quantum company seeking to build hardware domestically must either partner with an awardee, locate manufacturing offshore, or remain a pure-software or consulting play. This is not accidental. Federal supply-chain strategy, particularly in defense-adjacent domains like quantum computing, has long aimed to concentrate capability among verified, controllable partners.

A wrinkle arrived on May 25: a congressional legal challenge questioned whether the CHIPS Act authorizes the government to take equity stakes in private companies and whether the award process met statutory timelines and transparency requirements. The challenge does not invalidate the LOIs, but it introduces execution risk. If the challenge succeeds, the awards could be restructured or delayed; if it fails, it sets a precedent that opens the door to equity stakes in future CHIPS awards for other deep-tech sectors. The real open question is not whether Anderon or GlobalFoundries will eventually operate, but whether the 300mm shift will actually compress the timeline to economic viability for quantum systems, and whether domestic supply-chain control matters more than modality performance in determining which quantum architectures reach production volume first. Watch Anderon's Albany fab completion date, the first commercial wafers shipped, and whether non-awardee quantum companies announce offshore foundry partnerships or shift strategy toward software and classical hybrid approaches.